Feb. 11, 2020 13:00 UTC Eversense long-term CGM and InPen System to integrate sensor glucose and insulin data. GERMANTOWN, Md.--( BUSINESS WIRE )-- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system, today announced an agreement with Companion Medical to integrate Eversense ® CGM System real-time glucose data wi
February 11, 2020
· 7 min read